CollPlant Biotechnologies Ltd (CLGN)
Nasdaq: CLGN · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Rehovot, IL · filing with the SEC since 2015
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
| Report filed | Mar 26, 2026 | Mar 26, 2025 | Apr 4, 2024 | Mar 29, 2023 | Mar 24, 2022 | Mar 26, 2021 | Apr 1, 2020 | Apr 1, 2019 | Mar 20, 2018 |
| Revenue | 2,371 | 515 | 10,959 | 299 | 15,641 | 6,137 | 2,318 | 5,014 | · |
| Cost of revenue | 835 | 1,625 | 1,991 | 400 | 2,005 | 3,002 | 1,879 | 1,659 | · |
| Gross profit | 1,536 | -1,110 | 8,968 | -101 | 13,636 | 3,135 | 439 | 3,355 | · |
| Research and development | 8,187 | 10,515 | 10,484 | 10,255 | 7,631 | 4,065 | 4,414r | 3,877r | 584 |
| General and administrative | 4,832 | 5,626 | 5,996 | 6,741 | 5,940 | 4,669 | 3,656 | 3,723 | · |
| Total operating expenses | · | · | · | · | · | 34 | 3,303 | 2,180 | · |
| Operating income | -11,483 | -17,251 | -7,512 | -17,097 | 65 | -5,599 | -7,631 | -4,245 | · |
| Interest and investment income | 380 | 738 | 788 | 321 | 219 | 175 | 3,533 | · | · |
| Total non-operating income (expense) | -6 | 642 | 493 | 172 | 172 | -175 | -3,533 | · | · |
| Income tax expense | · | 45,991 | 59,993 | · | · | · | · | · | · |
| Net income including non-controlling interests | · | · | · | -16,925 | 237r | -5,774r | 11,164 | · | · |
| Net income | -11,489 | -16,609 | -7,019 | -16,925 | 237 | -5,774 | -11,164 | -6,249 | · |
| Earnings per share, basic | -0.94 | -1.45 | -0.62 | -1.53 | 0.02 | -0.84 | -2.23 | · | · |
| Earnings per share, diluted | -0.94 | -1.45 | -0.62 | -1.53 | 0.02 | -0.84 | -2.23 | · | · |
| Earnings per share, basic and diluted | · | · | · | · | · | 0.84 | 2.23 | 1.43 | · |
| Weighted average shares, basic | 12,203,269 | 11,454,180 | 11,389,168 | 11,033,310 | 9,968,972 | 6,886,955 | 4,986,381 | · | · |
| Weighted average shares, diluted | 12,203,269 | 11,454,180 | 11,389,168 | 11,033,310 | 11,966,788 | 6,886,955 | 4,986,381 | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | · | 6,886,955 | 4,986,381 | 4,384,585 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterest
us-gaap:InvestmentIncomeNetTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted